EA
KROS icon

Emerald Advisers’s Keros Therapeutics KROS Stock Holding History

Emerald Advisers’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-244,633
Closed -$3.87M – 259
2024
Q4 		$3.87M Buy
244,633
+89,088
+57% +$1.41M 0.15% 113
2024
Q3 		$9.03M Buy
+155,545
New +$9.03M 0.35% 93